[Federal Register Volume 73, Number 185 (Tuesday, September 23, 2008)]
[Pages 54841-54842]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-22313]



National Institutes of Health

Office of the Director, National Institutes of Health; Office of 
Biotechnology Activity; Recombinant DNA Research; Notice of a Meeting 
of an NIH Blue Ribbon Panel

    There will be a meeting of the NIH Blue Ribbon Panel to advise on 
the Risk Assessment of the National Emerging Infectious Diseases 
Laboratories (NEIDL). The meeting will be held on Tuesday, October 14, 
2008, at the Roxbury Center for the Arts, Hibernian Hall, 184 Dudley 
Street, Roxbury, MA

[[Page 54842]]

02119 from approximately 6:30 p.m. to 9:30 p.m.
    Discussions will focus on principles and strategies for effective 
community engagement. There will also be time allotted on the agenda 
for public comment.
    Sign up for public comment will begin at approximately 5:30 p.m. on 
October 14, 2008. In the event that time does not allow for all those 
interested to present oral comments, anyone may file written comments 
using the address below.
    For further information concerning this meeting contact Ms. Laurie 
Lewallen, Advisory Committee Coordinator, Office of Biotechnology 
Activities, Office of the Director, National Institutes of Health, Mail 
Stop Code 7985, Bethesda, MD 20892-7985, telephone 301-496-9838, e-mail 
[email protected]. Background information may be obtained by 
contacting NIH OBA by e-mail [email protected].

    Dated: September 16, 2008.
Kelly R. Fennington,
Special Assistant to the Director, Office of Biotechnology Activities, 
National Institutes of Health.
[FR Doc. E8-22313 Filed 9-22-08; 8:45 am]